Global Molecular Diagnostics Market

Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers), Genetic Tests, Microbiology, Others (Blood Screening, Neurological Disease and Cardiovascular Disease)), Technology (Polymerase Chain Reactions (PCR), Hybridization, DNA Sequencing, Microarray, Others (Electrophoresis) Players and Region - Global Market Outlook to 2030

Molecular Diagnostics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 2.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Molecular Diagnostics
Molecular Diagnostics is a laboratory tests that is used to identify a disease or the predisposition to a disease, this is done by analysing DNA, RNA or their proteins in humans or in the case of infections in microbes. It includes the clinical testing instruments that are used in hospitals, clinics, commercial laboratories, reference laboratories and research institutes to detect cells and proteins for the purpose of diagnosis and monitoring disease. Molecular Diagnostics contribute to the identification and fine description of the genetic basis of inherited diseases which is vital for the accurate provision of diagnosis.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Billion)
CAGR2.8%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through new development, expansions and acquisitions across the globe to avail competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Molecular Diagnostics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), Agilent Technologies (United States), BioMérieux (France), DiaSorin (Italy), Becton Dickinson and Company (United States), Grifols (Spain), Hologic (United States), Qiagen (Germany), Roche Diagnostics (Switzerland), Siemens AG (Germany) and Bio-Rad Laboratories, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thermo Fisher Scientific (United States), Sysmex Corporation (Japan), F. Hoffmann-la Roche Ltd (Switzerland) and Myriad Genetics (United States).

Segmentation Overview
AMA Research has segmented the market of Global Molecular Diagnostics market by Type (Instruments, Reagents and Software & Services), Application (Infectious Diseases [HIV, HPV, Tuberculosis and Other Infectious Diseases], Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers], Genetic Tests, Microbiology and Others [Blood Screening, Neurological Disease and Cardiovascular Disease]) and Region.



On the basis of geography, the market of Molecular Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by Technology, the sub-segment i.e. Polymerase Chain Reactions (PCR) will boost the Molecular Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Incidence of Infectious Diseases and Increasing prevalence of infectious diseases and cancer

Market Growth Drivers:
Increasing Demand for Point of Care Diagnostics and Growing Acceptance of Personalized Medicine by Individuals

Challenges:
Lack of Skilled Professionals in Developing Economies and Limited Budgets for R&D

Restraints:
High Cost of Molecular Diagnostics and Need for High-Complexity Testing Centers

Opportunities:
Technological Advancements in Molecular Diagnostics, Increasing Infrastructure Development in Emerging Economies and Growth opportunities in emerging countries

Market Leaders and their expansionary development strategies
March 2, 2021 Royal Philips, a global leader in health technology, and Hologic, Inc., an innovative women’s health company, announced today a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics and services for screening, diagnosis and treatment of women across the world.
March 19, 2022 Abbott announced CE Mark for its Alinity m diagnostics system and assays. This new technology will help keep up with the growing demand for infectious disease testing. Alinity m will provide unprecedented flexibility in molecular diagnostic testing, allowing more tests to be done in shorter timeframes while reducing the space and number of instruments needed to conduct large amounts of tests.


Key Target Audience
Suppliers of Molecular Diagnostics, Wholesalers, Distributers and Retailers of Molecular Diagnostics, Healthcare Industry, Academic Laboratories and Research Center and Governmental Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Reagents
  • Software & Services
By Application
  • Infectious Diseases [HIV, HPV, Tuberculosis and Other Infectious Diseases]
  • Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers]
  • Genetic Tests
  • Microbiology
  • Others [Blood Screening, Neurological Disease and Cardiovascular Disease]
By Technology
  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Others [Electrophoresis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Point of Care Diagnostics
      • 3.2.2. Growing Acceptance of Personalized Medicine by Individuals
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals in Developing Economies
      • 3.3.2. Limited Budgets for R&D
    • 3.4. Market Trends
      • 3.4.1. Increasing Incidence of Infectious Diseases
      • 3.4.2. Increasing prevalence of infectious diseases and cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Diagnostics, by Type, Application, Technology and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Molecular Diagnostics (Value)
      • 5.2.1. Global Molecular Diagnostics by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents
        • 5.2.1.3. Software & Services
      • 5.2.2. Global Molecular Diagnostics by: Application (Value)
        • 5.2.2.1. Infectious Diseases [HIV, HPV, Tuberculosis and Other Infectious Diseases]
        • 5.2.2.2. Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers]
        • 5.2.2.3. Genetic Tests
        • 5.2.2.4. Microbiology
        • 5.2.2.5. Others [Blood Screening, Neurological Disease and Cardiovascular Disease]
      • 5.2.3. Global Molecular Diagnostics by: Technology (Value)
        • 5.2.3.1. Polymerase Chain Reactions (PCR)
        • 5.2.3.2. Hybridization
        • 5.2.3.3. DNA Sequencing
        • 5.2.3.4. Microarray
        • 5.2.3.5. Others [Electrophoresis
      • 5.2.4. Global Molecular Diagnostics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Molecular Diagnostics (Price)
      • 5.3.1. Global Molecular Diagnostics by: Type (Price)
  • 6. Molecular Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioMérieux (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DiaSorin (Italy)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Grifols (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hologic (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Qiagen (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roche Diagnostics (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Siemens AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Molecular Diagnostics Sale, by Type, Application, Technology and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Molecular Diagnostics (Value)
      • 7.2.1. Global Molecular Diagnostics by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents
        • 7.2.1.3. Software & Services
      • 7.2.2. Global Molecular Diagnostics by: Application (Value)
        • 7.2.2.1. Infectious Diseases [HIV, HPV, Tuberculosis and Other Infectious Diseases]
        • 7.2.2.2. Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers]
        • 7.2.2.3. Genetic Tests
        • 7.2.2.4. Microbiology
        • 7.2.2.5. Others [Blood Screening, Neurological Disease and Cardiovascular Disease]
      • 7.2.3. Global Molecular Diagnostics by: Technology (Value)
        • 7.2.3.1. Polymerase Chain Reactions (PCR)
        • 7.2.3.2. Hybridization
        • 7.2.3.3. DNA Sequencing
        • 7.2.3.4. Microarray
        • 7.2.3.5. Others [Electrophoresis
      • 7.2.4. Global Molecular Diagnostics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Molecular Diagnostics (Price)
      • 7.3.1. Global Molecular Diagnostics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Diagnostics: by Type(USD Billion)
  • Table 2. Molecular Diagnostics Instruments , by Region USD Billion (2018-2023)
  • Table 3. Molecular Diagnostics Reagents , by Region USD Billion (2018-2023)
  • Table 4. Molecular Diagnostics Software & Services , by Region USD Billion (2018-2023)
  • Table 5. Molecular Diagnostics: by Application(USD Billion)
  • Table 6. Molecular Diagnostics Infectious Diseases [HIV, HPV, Tuberculosis and Other Infectious Diseases] , by Region USD Billion (2018-2023)
  • Table 7. Molecular Diagnostics Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers] , by Region USD Billion (2018-2023)
  • Table 8. Molecular Diagnostics Genetic Tests , by Region USD Billion (2018-2023)
  • Table 9. Molecular Diagnostics Microbiology , by Region USD Billion (2018-2023)
  • Table 10. Molecular Diagnostics Others [Blood Screening, Neurological Disease and Cardiovascular Disease] , by Region USD Billion (2018-2023)
  • Table 11. Molecular Diagnostics: by Technology(USD Billion)
  • Table 12. Molecular Diagnostics Polymerase Chain Reactions (PCR) , by Region USD Billion (2018-2023)
  • Table 13. Molecular Diagnostics Hybridization , by Region USD Billion (2018-2023)
  • Table 14. Molecular Diagnostics DNA Sequencing , by Region USD Billion (2018-2023)
  • Table 15. Molecular Diagnostics Microarray , by Region USD Billion (2018-2023)
  • Table 16. Molecular Diagnostics Others [Electrophoresis , by Region USD Billion (2018-2023)
  • Table 17. South America Molecular Diagnostics, by Country USD Billion (2018-2023)
  • Table 18. South America Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 19. South America Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 20. South America Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 21. Brazil Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 22. Brazil Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 23. Brazil Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 24. Argentina Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 25. Argentina Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 26. Argentina Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 27. Rest of South America Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 28. Rest of South America Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 29. Rest of South America Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 30. Asia Pacific Molecular Diagnostics, by Country USD Billion (2018-2023)
  • Table 31. Asia Pacific Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 32. Asia Pacific Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 33. Asia Pacific Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 34. China Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 35. China Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 36. China Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 37. Japan Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 38. Japan Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 39. Japan Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 40. India Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 41. India Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 42. India Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 43. South Korea Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 44. South Korea Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 45. South Korea Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 46. Taiwan Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 47. Taiwan Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 48. Taiwan Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 49. Australia Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 50. Australia Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 51. Australia Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 52. Rest of Asia-Pacific Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 53. Rest of Asia-Pacific Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 54. Rest of Asia-Pacific Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 55. Europe Molecular Diagnostics, by Country USD Billion (2018-2023)
  • Table 56. Europe Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 57. Europe Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 58. Europe Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 59. Germany Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 60. Germany Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 61. Germany Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 62. France Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 63. France Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 64. France Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 65. Italy Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 66. Italy Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 67. Italy Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 68. United Kingdom Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 69. United Kingdom Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 70. United Kingdom Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 71. Netherlands Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 72. Netherlands Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 73. Netherlands Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 74. Rest of Europe Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 75. Rest of Europe Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 76. Rest of Europe Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 77. MEA Molecular Diagnostics, by Country USD Billion (2018-2023)
  • Table 78. MEA Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 79. MEA Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 80. MEA Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 81. Middle East Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 82. Middle East Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 83. Middle East Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 84. Africa Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 85. Africa Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 86. Africa Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 87. North America Molecular Diagnostics, by Country USD Billion (2018-2023)
  • Table 88. North America Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 89. North America Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 90. North America Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 91. United States Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 92. United States Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 93. United States Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 94. Canada Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 95. Canada Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 96. Canada Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 97. Mexico Molecular Diagnostics, by Type USD Billion (2018-2023)
  • Table 98. Mexico Molecular Diagnostics, by Application USD Billion (2018-2023)
  • Table 99. Mexico Molecular Diagnostics, by Technology USD Billion (2018-2023)
  • Table 100. Molecular Diagnostics: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Molecular Diagnostics: by Type(USD Billion)
  • Table 113. Molecular Diagnostics Instruments , by Region USD Billion (2025-2030)
  • Table 114. Molecular Diagnostics Reagents , by Region USD Billion (2025-2030)
  • Table 115. Molecular Diagnostics Software & Services , by Region USD Billion (2025-2030)
  • Table 116. Molecular Diagnostics: by Application(USD Billion)
  • Table 117. Molecular Diagnostics Infectious Diseases [HIV, HPV, Tuberculosis and Other Infectious Diseases] , by Region USD Billion (2025-2030)
  • Table 118. Molecular Diagnostics Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer and Other Cancers] , by Region USD Billion (2025-2030)
  • Table 119. Molecular Diagnostics Genetic Tests , by Region USD Billion (2025-2030)
  • Table 120. Molecular Diagnostics Microbiology , by Region USD Billion (2025-2030)
  • Table 121. Molecular Diagnostics Others [Blood Screening, Neurological Disease and Cardiovascular Disease] , by Region USD Billion (2025-2030)
  • Table 122. Molecular Diagnostics: by Technology(USD Billion)
  • Table 123. Molecular Diagnostics Polymerase Chain Reactions (PCR) , by Region USD Billion (2025-2030)
  • Table 124. Molecular Diagnostics Hybridization , by Region USD Billion (2025-2030)
  • Table 125. Molecular Diagnostics DNA Sequencing , by Region USD Billion (2025-2030)
  • Table 126. Molecular Diagnostics Microarray , by Region USD Billion (2025-2030)
  • Table 127. Molecular Diagnostics Others [Electrophoresis , by Region USD Billion (2025-2030)
  • Table 128. South America Molecular Diagnostics, by Country USD Billion (2025-2030)
  • Table 129. South America Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 130. South America Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 131. South America Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 132. Brazil Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 133. Brazil Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 134. Brazil Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 135. Argentina Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 136. Argentina Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 137. Argentina Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 138. Rest of South America Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 139. Rest of South America Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 140. Rest of South America Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 141. Asia Pacific Molecular Diagnostics, by Country USD Billion (2025-2030)
  • Table 142. Asia Pacific Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 143. Asia Pacific Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 144. Asia Pacific Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 145. China Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 146. China Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 147. China Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 148. Japan Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 149. Japan Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 150. Japan Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 151. India Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 152. India Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 153. India Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 154. South Korea Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 155. South Korea Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 156. South Korea Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 157. Taiwan Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 158. Taiwan Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 159. Taiwan Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 160. Australia Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 161. Australia Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 162. Australia Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 163. Rest of Asia-Pacific Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 164. Rest of Asia-Pacific Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 165. Rest of Asia-Pacific Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 166. Europe Molecular Diagnostics, by Country USD Billion (2025-2030)
  • Table 167. Europe Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 168. Europe Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 169. Europe Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 170. Germany Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 171. Germany Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 172. Germany Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 173. France Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 174. France Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 175. France Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 176. Italy Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 177. Italy Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 178. Italy Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 179. United Kingdom Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 180. United Kingdom Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 181. United Kingdom Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 182. Netherlands Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 183. Netherlands Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 184. Netherlands Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 185. Rest of Europe Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 186. Rest of Europe Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 187. Rest of Europe Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 188. MEA Molecular Diagnostics, by Country USD Billion (2025-2030)
  • Table 189. MEA Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 190. MEA Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 191. MEA Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 192. Middle East Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 193. Middle East Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 194. Middle East Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 195. Africa Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 196. Africa Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 197. Africa Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 198. North America Molecular Diagnostics, by Country USD Billion (2025-2030)
  • Table 199. North America Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 200. North America Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 201. North America Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 202. United States Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 203. United States Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 204. United States Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 205. Canada Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 206. Canada Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 207. Canada Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 208. Mexico Molecular Diagnostics, by Type USD Billion (2025-2030)
  • Table 209. Mexico Molecular Diagnostics, by Application USD Billion (2025-2030)
  • Table 210. Mexico Molecular Diagnostics, by Technology USD Billion (2025-2030)
  • Table 211. Molecular Diagnostics: by Type(USD/Units)
  • Table 212. Research Programs/Design for This Report
  • Table 213. Key Data Information from Secondary Sources
  • Table 214. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Diagnostics: by Type USD Billion (2018-2023)
  • Figure 5. Global Molecular Diagnostics: by Application USD Billion (2018-2023)
  • Figure 6. Global Molecular Diagnostics: by Technology USD Billion (2018-2023)
  • Figure 7. South America Molecular Diagnostics Share (%), by Country
  • Figure 8. Asia Pacific Molecular Diagnostics Share (%), by Country
  • Figure 9. Europe Molecular Diagnostics Share (%), by Country
  • Figure 10. MEA Molecular Diagnostics Share (%), by Country
  • Figure 11. North America Molecular Diagnostics Share (%), by Country
  • Figure 12. Global Molecular Diagnostics: by Type USD/Units (2018-2023)
  • Figure 13. Global Molecular Diagnostics share by Players 2023 (%)
  • Figure 14. Global Molecular Diagnostics share by Players (Top 3) 2023(%)
  • Figure 15. Global Molecular Diagnostics share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 19. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 20. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 21. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 22. BioMérieux (France) Revenue: by Geography 2023
  • Figure 23. DiaSorin (Italy) Revenue, Net Income and Gross profit
  • Figure 24. DiaSorin (Italy) Revenue: by Geography 2023
  • Figure 25. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 27. Grifols (Spain) Revenue, Net Income and Gross profit
  • Figure 28. Grifols (Spain) Revenue: by Geography 2023
  • Figure 29. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hologic (United States) Revenue: by Geography 2023
  • Figure 31. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Qiagen (Germany) Revenue: by Geography 2023
  • Figure 33. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Roche Diagnostics (Switzerland) Revenue: by Geography 2023
  • Figure 35. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Siemens AG (Germany) Revenue: by Geography 2023
  • Figure 37. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 39. Global Molecular Diagnostics: by Type USD Billion (2025-2030)
  • Figure 40. Global Molecular Diagnostics: by Application USD Billion (2025-2030)
  • Figure 41. Global Molecular Diagnostics: by Technology USD Billion (2025-2030)
  • Figure 42. South America Molecular Diagnostics Share (%), by Country
  • Figure 43. Asia Pacific Molecular Diagnostics Share (%), by Country
  • Figure 44. Europe Molecular Diagnostics Share (%), by Country
  • Figure 45. MEA Molecular Diagnostics Share (%), by Country
  • Figure 46. North America Molecular Diagnostics Share (%), by Country
  • Figure 47. Global Molecular Diagnostics: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Agilent Technologies (United States)
  • BioMérieux (France)
  • DiaSorin (Italy)
  • Becton Dickinson and Company (United States)
  • Grifols (Spain)
  • Hologic (United States)
  • Qiagen (Germany)
  • Roche Diagnostics (Switzerland)
  • Siemens AG (Germany)
  • Bio-Rad Laboratories, Inc. (United States)
Additional players considered in the study are as follows:
Thermo Fisher Scientific (United States) , Sysmex Corporation (Japan) , F. Hoffmann-la Roche Ltd (Switzerland) , Myriad Genetics (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 178 Pages 66 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Molecular Diagnostics Market Quantitative research analysis
Global Molecular Diagnostics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboratories (United States), Agilent Technologies (United States), BioMérieux (France), DiaSorin (Italy), Becton Dickinson and Company (United States), Grifols (Spain), Hologic (United States), Qiagen (Germany), Roche Diagnostics (Switzerland), Siemens AG (Germany) and Bio-Rad Laboratories, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Incidence of Infectious Diseases " is seen as one of major influencing trends for Molecular Diagnostics Market during projected period 2023-2030.
The Molecular Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Molecular Diagnostics Market to reach USD31.8 Billion by 2030.

Know More About Global Molecular Diagnostics Market Report?

Have a Query? Click Here

Other Related Reports

Thyroid Function Tests Comprehensive Study by Type (TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), FT3 Tests (Free T3)), End User (Hospitals, Diagnostic Laboratories, Research Lab...
$ 3350
Cancer Profiling Comprehensive Study by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Others (Melanoma, Colorectal, Bladder, Leukemia)), Application (Clinical, Scr...
$ 3750
Multipurpose Systems Comprehensive Study by Application (Ambulance, RHC, Home care, Intensive care room), Components (Hardware, Software), Modules (Biosignal acquisition module, Digital camera, Proce...
$ 3450
Fertility Services Comprehensive Study by Application (Fertility clinics, Hospitals, Surgical centers, Clinical Research Institutes), Treatment (Assistive reproductive technology (ART) (Artificial in...
$ 3750
Healthcare Interoperability Solutions Comprehensive Study by Type (Software Solutions {EMR/EHR, Lab Systems, Imaging Systems, Healthcare Information Exchange, Enterprise, Other(Medical Billing, Pract...
$ 3750
Dental Restorative Comprehensive Study by Type (Dental amalgams, Dental cements, Dental composites, Dental ceramics, Dental liners), Application (Prosthodontics, Periodontics,, Periodontics), End Use...
$ 3450